Teva Pharmaceutical Q2 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
5 months ago
- Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q2 earnings results on Wednesday, July 31st, before market open.
- The consensus EPS Estimate is $0.55 (-1.8% Y/Y) and the consensus Revenue Estimate is $4.05B (+3.8% Y/Y).
- Over the last 2 years, TEVA has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 4 downward. Revenue estimates have seen 3 upward revisions and 1 downward.
- Recent earnings Analysis from our contributors:Teva’s Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs